Acumen Pharmaceuticals 미래 성장
Future 기준 확인 0/6
Acumen Pharmaceuticals's earnings are forecast to decline at 7.7% per annum while its annual revenue is expected to grow at 82.1% per year. EPS is expected to decline by 4% per annum. Return on equity is forecast to be -99.1% in 3 years.
주요 정보
-7.7%
수익 성장률
-4.0%
EPS 성장률
| Biotechs 수익 성장 | 27.1% |
| 매출 성장률 | 82.1% |
| 향후 자기자본 수익률 | -99.1% |
| 애널리스트 커버리지 | Low |
| 마지막 업데이트 | 03 Oct 2024 |
최근 미래 성장 업데이트
Recent updates
Does Acumen Pharmaceuticals (NASDAQ:ABOS) Have A Healthy Balance Sheet?
Aug 05
Acumen Pharmaceuticals: Healthy Cash Runway And Market Potential In Alzheimer's
Jul 30Is Acumen Pharmaceuticals (NASDAQ:ABOS) Weighed On By Its Debt Load?
Apr 21Companies Like Acumen Pharmaceuticals (NASDAQ:ABOS) Are In A Position To Invest In Growth
Sep 21We're Not Very Worried About Acumen Pharmaceuticals' (NASDAQ:ABOS) Cash Burn Rate
Feb 01Acumen Pharmaceuticals (NASDAQ:ABOS) Is In A Good Position To Deliver On Growth Plans
Oct 16Acumen Pharma at 11-month high on rivals’ Alzheimer’s data
Sep 28Acumen Pharmaceuticals initiated at buy at H.C. Wainwright on Alzheimer's candidate
Jun 30We Think Acumen Pharmaceuticals (NASDAQ:ABOS) Can Afford To Drive Business Growth
May 10We're Not Very Worried About Acumen Pharmaceuticals' (NASDAQ:ABOS) Cash Burn Rate
Jan 07Acumen Pharmaceuticals (NASDAQ:ABOS) Is In A Good Position To Deliver On Growth Plans
Oct 01수익 및 매출 성장 예측
| 날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
|---|---|---|---|---|---|
| 12/31/2026 | N/A | -88 | -129 | -137 | 3 |
| 12/31/2025 | N/A | -100 | -104 | -115 | 4 |
| 12/31/2024 | N/A | -82 | -79 | -79 | 4 |
| 6/30/2024 | N/A | -65 | -56 | -56 | N/A |
| 3/31/2024 | N/A | -56 | -51 | -51 | N/A |
| 12/31/2023 | N/A | -52 | -43 | -43 | N/A |
| 9/30/2023 | N/A | -49 | -46 | -46 | N/A |
| 6/30/2023 | N/A | -46 | -42 | -42 | N/A |
| 3/31/2023 | N/A | -45 | -37 | -37 | N/A |
| 12/31/2022 | N/A | -43 | -35 | -35 | N/A |
| 9/30/2022 | N/A | -38 | -28 | -28 | N/A |
| 6/30/2022 | N/A | -32 | -26 | -26 | N/A |
| 3/31/2022 | N/A | -83 | -24 | -24 | N/A |
| 12/31/2021 | N/A | -101 | -18 | -18 | N/A |
| 9/30/2021 | 0 | -93 | -17 | -17 | N/A |
| 6/30/2021 | 1 | -92 | -11 | -11 | N/A |
| 3/31/2021 | 1 | -32 | -8 | -8 | N/A |
| 12/31/2020 | 1 | -7 | -7 | -7 | N/A |
| 12/31/2019 | 2 | -8 | -7 | -7 | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: ABOS is forecast to remain unprofitable over the next 3 years.
수익 vs 시장: ABOS is forecast to remain unprofitable over the next 3 years.
고성장 수익: ABOS is forecast to remain unprofitable over the next 3 years.
수익 대 시장: ABOS is forecast to have no revenue next year.
고성장 수익: ABOS is forecast to have no revenue next year.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: ABOS is forecast to be unprofitable in 3 years.